Christian Trepo spends much of his time researching Virology, Hepatitis B virus, Immunology, Internal medicine and Gastroenterology. His research in Virus, Hepadnaviridae, Hepatitis C virus, Viral load and Viral disease are components of Virology. His Hepatitis B virus research focuses on Hepatitis B and how it connects with Transplantation.
Christian Trepo works mostly in the field of Immunology, limiting it down to topics relating to Hepatocellular carcinoma and, in certain cases, Case-control study, as a part of the same area of interest. His Internal medicine research is multidisciplinary, incorporating perspectives in Interferon alfa and Ribavirin. He has researched Gastroenterology in several fields, including Odds ratio, Liver transplantation, Surgery, Peginterferon alfa-2b and Fibrosis.
Virology, Immunology, Internal medicine, Hepatitis B virus and Virus are his primary areas of study. His Virology research incorporates themes from Molecular biology, Antibody and Antigen. Christian Trepo interconnects Gastroenterology and Surgery in the investigation of issues within Internal medicine.
His Hepatitis B virus study frequently links to other fields, such as Hepatitis B. His studies in Hepatitis C virus integrate themes in fields like Viral load and Genotype. His Cirrhosis research is multidisciplinary, incorporating elements of Liver disease and Hepatocellular carcinoma.
His main research concerns Virology, Internal medicine, Immunology, Hepatitis B virus and Gastroenterology. He studies Virus which is a part of Virology. His studies examine the connections between Internal medicine and genetics, as well as such issues in Viral load, with regards to Viremia, Pharmacodynamics and Viral disease.
He has researched Immunology in several fields, including Hepatocellular carcinoma and Hepatology. While the research belongs to areas of Hepatitis B virus, Christian Trepo spends his time largely on the problem of Hepatitis B, intersecting his research to questions surrounding Hepatitis, Risk factor, Serum markers and Pharmacotherapy. His work carried out in the field of Gastroenterology brings together such families of science as Odds ratio and Randomized controlled trial.
Christian Trepo mostly deals with Virology, Hepatitis B virus, Immunology, Hepatitis B and Internal medicine. As part of his studies on Virology, he often connects relevant areas like Liver enzyme. His study in Hepatitis B virus concentrates on Lamivudine and Adefovir.
His study in HBsAg, Viral load and Interferon is done as part of Immunology. Christian Trepo regularly links together related areas like Gastroenterology in his Internal medicine studies. His Gastroenterology research focuses on Hepatitis C virus and how it relates to Hepatitis C and Risk factor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)
Thierry Poynard;Patrick Marcellin;Samuel S Lee;Christian Niederau.
The Lancet (1998)
Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C
Gary L. Davis;Rafael Esteban-Mur;Vinod Rustgi;John Hoefs.
The New England Journal of Medicine (1998)
Hepatitis B virus infection
Christian Trépo;Henry L Y Chan;Anna Lok.
The Lancet (2014)
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.
Thierry Poynard;John McHutchison;Michael Manns;Christian Trepo.
Infection of a human hepatoma cell line by hepatitis B virus
Philippe Gripon;Sylvie Rumin;Stephan Urban;Jacques Le Seyec.
Proceedings of the National Academy of Sciences of the United States of America (2002)
A proposed system for the nomenclature of hepatitis C viral genotypes
P Simmonds;A Alberti;H J Alter;F Bonino.
Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C
John G. McHutchison;Michael Manns;Keyur Patel;Thierry Poynard.
Persistence of cccDNA During the Natural History of Chronic Hepatitis B and Decline During Adefovir Dipivoxil Therapy
Bettina Werle-Lapostolle;Scott Bowden;Stephen Locarnini;Karsten Wursthorn;Karsten Wursthorn.
Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.
M Rizzetto;Mg Canese;S Arico;O Crivelli.
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.
Karen L. Lindsay;Christian Trepo;Tobias Heintges;Mitchell L. Shiffman.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: